Facts Matter (April 13): New Documents Show NIH Funded ‘Gain-of-Function’ Research in China: Expert’s Analysis

According to a treasure trove of about 10,000 pages of government documents, it turns out that the NIH was in fact funding virus alteration research over at the Wuhan Institute of Virology. Specifically, the money was being funneled through a subgrant given to an organization called the EcoHealth Alliance. And what the researchers were doing was taking bat coronaviruses, altering them, and then seeing what these newly created viruses were doing inside of humanized mice.

And according to the interim reports, which were included within this treasure trove of documents, it turns out that these lab-created viruses were at least 300 percent more deadly. However, the NIH came out after this fact was revealed, and they said that what they were doing did not qualify as gain-of-function research.

Resources:

American Hartford Gold (866-242-2352):

https://ept.ms/3biH9MN

NIH:

https://ept.ms/3xqz7MV

https://ept.ms/3rnGrFe

https://ept.ms/3xnLp8P

https://ept.ms/3M4JdaA

Interim Report:

https://ept.ms/3vhp7TF

Dr. Tabak Letter:

https://ept.ms/3xqQkpy


Stay tuned for our newsletter so you won’t miss out on our exclusive videos and private events.

Facts Matter is an Epoch Times show available on YouTube.

Follow Roman on Instagram: @epoch.times.roman

Listen to Podcasts:
iTunes Podcast: https://ept.ms/FactsMatterApplePodcast
Spotify Podcast: https://ept.ms/FactsMatterSpotifyPodcast
Google Podcast: https://ept.ms/FactsMatterGooglePodcast

Follow EpochTV on social media:

Facebook: https://www.facebook.com/EpochTVus
Twitter: https://twitter.com/EpochTVus
Rumble: https://rumble.com/c/EpochTV

Gettr: https://gettr.com/user/epochtv
Gab: https://gab.com/EpochTV
Telegram: https://t.me/EpochTV
Parler: https://parler.com/#/user/EpochTV

ntd newsletter icon
Sign up for NTD Daily
What you need to know, summarized in one email.
Stay informed with accurate news you can trust.
By registering for the newsletter, you agree to the Privacy Policy.
Comments